TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

Supply of Additive Solutions for the Suspension of Blood Products

Blood-transfusion supplies
South West (UKK11)
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: NHS Blood and Transplant: "Supply of Additive Solutions for the Suspension of Blood Products". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityNHS Blood and TransplantScope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: NHS Blood and Transplant
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for NHS Blood and Transplant. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
1.7Bids / Report
56.5% of reports have one bid
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 27 active published awards; 23 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityNHS Blood and Transplant
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSFramework
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published21 Dec 2022, 11:03 GMT
Last source update21 Dec 2022, 11:03 GMT
Recurring procurementNot published
ClassificationBlood-transfusion supplies
Delivery area
South West (UKK11)
OCIDocds-h6vhtk-039338
What is being bought
NHSBT uses Platelet Additive Solution (PAS) for the suspension and storage of pooled platelets, and Saline Adenine Glucose Mannitol (SAGM) solution in the manufacture and storage of washed red cells.<br/><br/>The framework agreement was awarded to MacoParma after an OJEU open tender exercise on behalf of selected beneficiaries (blood services from the UK, Ireland, Australia and New Zealand).
What changed
From the official release history
  1. Status changed to complete
    21 Dec 2022, 11:03 GMT
  2. Official notice release published
    21 Dec 2022, 11:03 GMT
  3. Buyer information updated
    21 Dec 2022, 11:03 GMT
Lots and requirements (1)
Published by the contracting authority
  • Lot 1 · #1
    Individual lot title not published
    Status not published
    Published valueNot published
    This Framework Agreement was let for a period of 4-years starting on 01/12/2018, and expired on 30/11/2022. Due to circumstances outside of the Authority's control, including dealing with the impact of Covid-19 and a related procurement exercise being delayed, the Authority wishes to extend this Framework Agreement by 1-Year. This extension will allow the Authority adequate time to complete the related procurement exercise, and allow sufficient time to carry out the required validation exercise for the retendering of this requirement.<br/><br/>Therefore, this VEAT notice will cover the period 1 December 2022 to 30 November 2023.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    21 Dec 2022, 11:03 GMT
  2. Award active
    Not published · Not published
  3. Contract active
    Signed 1 Dec 2022, 00:00 GMT · £464,000
Commercial outcome and competition
Awards
MacoPharma UK Limited
Not published · Not published · active
Contracts
Contract
£464,000 · signed 1 Dec 2022, 00:00 GMT · active
Bid statisticsNo aggregate bid statistics published
Buyer and organisations in this procedure

NHS Blood and Transplant

Contracting authority GB-FTS-17015
View buyer profile

  • NHS Blood and Transplant
    buyer

    NHS Blood and Transplant
    500 North Bristol Park, Bristol, UKK11, BS34 7QH
    samantha.rix@nhsbt.nhs.uk
    +44 7385972251

  • MacoPharma UK Limited
    supplier

    01986987
    9th Floor- Regal House, 70 London Road, Twickenham, Middlesex,, Twickenham, UK, TW13QS
    +44 7764253357

  • The High Court
    reviewBody

    The Strand, London, WC2A 2LL
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published
Planning and rationale
Planning budgetNot published
No-engagement rationaleNot published
Procedure rationaleThis Framework Agreement was let for a period of 4-years starting on 01/12/2018, and expired on 30/11/2022. Due to circumstances outside of the Authority's control, including dealing with the impact of Covid-19 and a related procurement exercise being delayed, the Authority wishes to extend this Framework Agreement by 1-Year. This extension will allow the authority adequate time to complete the related procurement exercise, and allow sufficient time to carry out the required validation exercise for the retendering of this requirement.<br/><br/>Therefore, this VEAT notice will cover the period 1 December 2022 to 30 November 2023.